A case of multiple metastatic gastric cancer with primary lesion vanished after administrating nivolumab, and the effect remains even after discontinuance of therapy

Nivolumab is one of the immune checkpoint inhibitors available for chemotherapy-resistant gastric cancer. There have been few reports of confirmed prominent shrinkage of the primary tumor and some reports of prolonged antitumor effect after discontinuance of the drug, but it is not universal. A 67-y...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int Cancer Conf J
Hauptverfasser: Doi, Hirofumi, Ninomiya, Motoki, Toyota, Kazuhiro, Hirahara, Satoshi, Kuhara, Yuta, Shirakawa, Kenji, Yano, Raita, Kobayashi, Hironori, Hashimoto, Yasushi, Yokoyama, Yujiro, Sakashita, Yoshihiro, Miyamoto, Katsunari
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Singapore 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7450005/
https://ncbi.nlm.nih.gov/pubmed/32904060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-020-00432-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge